Logo image of ELMD

ELECTROMED INC (ELMD) Stock Fundamental Analysis

NYSEARCA:ELMD - NYSE Arca - US2854091087 - Common Stock - Currency: USD

23.2  +0.15 (+0.65%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to ELMD. ELMD was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making ELMD a very profitable company, without any liquidiy or solvency issues. ELMD is not overvalued while it is showing excellent growth. This is an interesting combination. This makes ELMD very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year ELMD was profitable.
In the past year ELMD had a positive cash flow from operations.
ELMD had positive earnings in each of the past 5 years.
ELMD had a positive operating cash flow in 4 of the past 5 years.
ELMD Yearly Net Income VS EBIT VS OCF VS FCFELMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

Looking at the Return On Assets, with a value of 12.94%, ELMD belongs to the top of the industry, outperforming 94.71% of the companies in the same industry.
The Return On Equity of ELMD (15.51%) is better than 91.01% of its industry peers.
ELMD has a Return On Invested Capital of 14.95%. This is amongst the best in the industry. ELMD outperforms 96.30% of its industry peers.
ELMD had an Average Return On Invested Capital over the past 3 years of 8.56%. This is in line with the industry average of 7.71%.
The last Return On Invested Capital (14.95%) for ELMD is above the 3 year average (8.56%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.94%
ROE 15.51%
ROIC 14.95%
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ELMD Yearly ROA, ROE, ROICELMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With an excellent Profit Margin value of 11.34%, ELMD belongs to the best of the industry, outperforming 87.83% of the companies in the same industry.
In the last couple of years the Profit Margin of ELMD has grown nicely.
The Operating Margin of ELMD (14.52%) is better than 84.66% of its industry peers.
In the last couple of years the Operating Margin of ELMD has grown nicely.
Looking at the Gross Margin, with a value of 76.81%, ELMD belongs to the top of the industry, outperforming 89.42% of the companies in the same industry.
In the last couple of years the Gross Margin of ELMD has remained more or less at the same level.
Industry RankSector Rank
OM 14.52%
PM (TTM) 11.34%
GM 76.81%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
ELMD Yearly Profit, Operating, Gross MarginsELMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

ELMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ELMD has more shares outstanding than it did 1 year ago.
ELMD has more shares outstanding than it did 5 years ago.
There is no outstanding debt for ELMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ELMD Yearly Shares OutstandingELMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ELMD Yearly Total Debt VS Total AssetsELMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 16.76 indicates that ELMD is not in any danger for bankruptcy at the moment.
The Altman-Z score of ELMD (16.76) is better than 94.71% of its industry peers.
There is no outstanding debt for ELMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.76
ROIC/WACC1.69
WACC8.83%
ELMD Yearly LT Debt VS Equity VS FCFELMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 5.10 indicates that ELMD has no problem at all paying its short term obligations.
ELMD's Current ratio of 5.10 is fine compared to the rest of the industry. ELMD outperforms 74.60% of its industry peers.
A Quick Ratio of 4.74 indicates that ELMD has no problem at all paying its short term obligations.
ELMD's Quick ratio of 4.74 is fine compared to the rest of the industry. ELMD outperforms 78.84% of its industry peers.
Industry RankSector Rank
Current Ratio 5.1
Quick Ratio 4.74
ELMD Yearly Current Assets VS Current LiabilitesELMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.67% over the past year.
Measured over the past years, ELMD shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.42% on average per year.
ELMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.35%.
Measured over the past years, ELMD shows a quite strong growth in Revenue. The Revenue has been growing by 11.82% on average per year.
EPS 1Y (TTM)66.67%
EPS 3Y30.66%
EPS 5Y20.42%
EPS Q2Q%15.79%
Revenue 1Y (TTM)15.35%
Revenue growth 3Y15.24%
Revenue growth 5Y11.82%
Sales Q2Q%18.74%

3.2 Future

The Earnings Per Share is expected to grow by 26.83% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 12.42% on average over the next years. This is quite good.
EPS Next Y42.45%
EPS Next 2Y30.94%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue Next Year15.21%
Revenue Next 2Y13.44%
Revenue Next 3Y12.42%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ELMD Yearly Revenue VS EstimatesELMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ELMD Yearly EPS VS EstimatesELMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.93, the valuation of ELMD can be described as expensive.
Based on the Price/Earnings ratio, ELMD is valued a bit cheaper than the industry average as 73.55% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.75, ELMD is valued at the same level.
With a Price/Forward Earnings ratio of 23.33, ELMD is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELMD indicates a somewhat cheap valuation: ELMD is cheaper than 76.72% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ELMD to the average of the S&P500 Index (20.49), we can say ELMD is valued inline with the index average.
Industry RankSector Rank
PE 30.93
Fwd PE 23.33
ELMD Price Earnings VS Forward Price EarningsELMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ELMD is valued a bit cheaper than 76.19% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ELMD is valued cheaper than 88.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.34
EV/EBITDA 18.93
ELMD Per share dataELMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

ELMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of ELMD may justify a higher PE ratio.
ELMD's earnings are expected to grow with 26.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)1.51
EPS Next 2Y30.94%
EPS Next 3Y26.83%

More info and screens

0

5. Dividend

5.1 Amount

ELMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELECTROMED INC

NYSEARCA:ELMD (5/2/2025, 1:10:15 PM)

23.2

+0.15 (+0.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)05-13 2025-05-13
Inst Owners44.13%
Inst Owner Change-1.62%
Ins Owners7.62%
Ins Owner Change-5.27%
Market Cap198.59M
Analysts82.5
Price Target37.74 (62.67%)
Short Float %2.85%
Short Ratio2.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)221.35%
Min EPS beat(2)19.83%
Max EPS beat(2)422.88%
EPS beat(4)4
Avg EPS beat(4)127.74%
Min EPS beat(4)19.83%
Max EPS beat(4)422.88%
EPS beat(8)6
Avg EPS beat(8)65.62%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.34%
Min Revenue beat(2)4.16%
Max Revenue beat(2)6.52%
Revenue beat(4)2
Avg Revenue beat(4)1.54%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)6.52%
Revenue beat(8)4
Avg Revenue beat(8)0.83%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)12.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)24.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.69%
Valuation
Industry RankSector Rank
PE 30.93
Fwd PE 23.33
P/S 3.33
P/FCF 18.34
P/OCF 17.57
P/B 4.55
P/tB 4.62
EV/EBITDA 18.93
EPS(TTM)0.75
EY3.23%
EPS(NY)0.99
Fwd EY4.29%
FCF(TTM)1.27
FCFY5.45%
OCF(TTM)1.32
OCFY5.69%
SpS6.97
BVpS5.09
TBVpS5.02
PEG (NY)0.73
PEG (5Y)1.51
Profitability
Industry RankSector Rank
ROA 12.94%
ROE 15.51%
ROCE 19.85%
ROIC 14.95%
ROICexc 23.83%
ROICexgc 24.37%
OM 14.52%
PM (TTM) 11.34%
GM 76.81%
FCFM 18.16%
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ROICexc(3y)11.98%
ROICexc(5y)12.69%
ROICexgc(3y)12.25%
ROICexgc(5y)13.03%
ROCE(3y)11.36%
ROCE(5y)11.53%
ROICexcg growth 3Y14.49%
ROICexcg growth 5Y7.7%
ROICexc growth 3Y14.84%
ROICexc growth 5Y7.9%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
F-Score8
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 51.65%
Cap/Sales 0.79%
Interest Coverage 250
Cash Conversion 118.13%
Profit Quality 160.14%
Current Ratio 5.1
Quick Ratio 4.74
Altman-Z 16.76
F-Score8
WACC8.83%
ROIC/WACC1.69
Cap/Depr(3y)189.91%
Cap/Depr(5y)155.01%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.67%
EPS 3Y30.66%
EPS 5Y20.42%
EPS Q2Q%15.79%
EPS Next Y42.45%
EPS Next 2Y30.94%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue 1Y (TTM)15.35%
Revenue growth 3Y15.24%
Revenue growth 5Y11.82%
Sales Q2Q%18.74%
Revenue Next Year15.21%
Revenue Next 2Y13.44%
Revenue Next 3Y12.42%
Revenue Next 5YN/A
EBIT growth 1Y69.89%
EBIT growth 3Y27.97%
EBIT growth 5Y18.35%
EBIT Next Year137.93%
EBIT Next 3Y45.86%
EBIT Next 5YN/A
FCF growth 1Y521.07%
FCF growth 3Y48.86%
FCF growth 5Y48.48%
OCF growth 1Y1341.76%
OCF growth 3Y43.37%
OCF growth 5Y28.48%